----YOU ADS---
----YOU ADS---
----YOU ADS---
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19...
----YOU ADS---